Amussen Hunsaker Associates LLC Abb Vie Inc. Transaction History
Amussen Hunsaker Associates LLC
- $715 Million
- Q3 2024
A detailed history of Amussen Hunsaker Associates LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Amussen Hunsaker Associates LLC holds 1,367 shares of ABBV stock, worth $239,580. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,367
Previous 1,367
-0.0%
Holding current value
$239,580
Previous $234,000
14.96%
% of portfolio
0.04%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
3,877Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.9 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.17 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.79 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $310B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...